dual H1/H3 antagonists (GlaxoSmithKline)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namedual H1/H3 antagonists (GlaxoSmithKline)
Drug Alias Namedual H1/H3 antagonists (GSK)GSK-541636
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H3 receptor antagonistsHistamine H1 receptor antagonists
TargetsHistamine H3 receptorHistamine H1 receptor
Therapy Area/IndicationsRhinitis, Allergic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsRhinitis, Allergic

Other Information

ATC CodeN/A
Related LinksN/A